Article Details

Varian Receives Investigational Device Exemption (IDE) for Flash Technology Clinical Trial, FAST-02

Retrieved on: 2022-06-27 15:00:34

Tags for this article:

Click the tags to see associated articles and topics

Varian Receives Investigational Device Exemption (IDE) for Flash Technology Clinical Trial, FAST-02. View article details on hiswai:

Excerpt

... Food and Drug Administration (FDA) granted an Investigational Device... ... M.D., Senior Vice President and Chief Medical Officer of Varian.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up